| Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells SO Lee, X Li, E Hedrick, UH Jin, RB Tjalkens, DS Backos, L Li, Y Zhang, ... Molecular Endocrinology 28 (10), 1729-1739, 2014 | 111 | 2014 |
| Targeting NR4A1 (TR3) in cancer cells and tumors SO Lee, X Li, S Khan, S Safe Expert opinion on therapeutic targets 15 (2), 195-206, 2011 | 105 | 2011 |
| Structure-Dependent Modulation of Aryl Hydrocarbon Receptor-Mediated Activities by Flavonoids UH Jin, H Park, X Li, LA Davidson, C Allred, B Patil, G Jayaprakasha, ... Toxicological Sciences 164 (1), 205-217, 2018 | 93 | 2018 |
| Structure-dependent activation of NR4A2 (Nurr1) by 1, 1-bis (3′-indolyl)-1-(aromatic) methane analogs in pancreatic cancer cells X Li, SO Lee, S Safe Biochemical pharmacology 83 (10), 1445-1455, 2012 | 84 | 2012 |
| Penfluridol represses integrin expression in breast cancer through induction of reactive oxygen species and downregulation of Sp transcription factors E Hedrick, X Li, S Safe Molecular cancer therapeutics 16 (1), 205-216, 2017 | 52 | 2017 |
| Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors S Pathi, X Li, S Safe Molecular carcinogenesis 53 (S1), E53-E61, 2014 | 51 | 2014 |
| The Nurr1 Ligand, 1, 1-bis (3′-Indolyl)-1-(p-Chlorophenyl) Methane, Modulates Glial Reactivity and Is Neuroprotective in MPTP-Induced Parkinsonism SL Hammond, KA Popichak, X Li, LG Hunt, EH Richman, PU Damale, ... Journal of Pharmacology and Experimental Therapeutics 365 (3), 636-651, 2018 | 42 | 2018 |
| Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS) A Lacey, E Hedrick, X Li, K Patel, R Doddapaneni, M Singh, S Safe Oncotarget 7 (21), 31257, 2016 | 32 | 2016 |
| NR4A orphan receptors and cancer S Safe, K Kim, X Li, SO Lee Nucl Recept Signal 9, e002, 2011 | 32 | 2011 |
| Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists E Hedrick, X Li, Y Cheng, A Lacey, K Mohankumar, M Zarei, S Safe Breast cancer research and treatment 177 (1), 29-40, 2019 | 31 | 2019 |
| Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors X Li, SS Pathi, S Safe BMC cancer 15 (1), 974, 2015 | 28 | 2015 |
| Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas K Karki, X Li, UH Jin, K Mohankumar, M Zarei, SK Michelhaugh, S Mittal, ... Journal of neuro-oncology 146 (1), 25-39, 2020 | 26 | 2020 |
| Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer K Mohankumar, X Li, S Sridharan, K Karki, S Safe Gynecologic oncology 154 (1), 218-227, 2019 | 21 | 2019 |
| Bis-Indole–Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis K Mohankumar, X Li, N Sung, YJ Cho, SJ Han, S Safe Endocrinology 161 (4), bqaa027, 2020 | 18 | 2020 |
| Structure‐dependent activation of gene expression by bis‐indole and quinoline‐derived activators of nuclear receptor 4A2 X Li, RB Tjalkens, R Shrestha, S Safe Chemical biology & drug design 94 (4), 1711-1720, 2019 | 16 | 2019 |
| Template-free fabrication of vertically-aligned polymer nanowire array on the flat-end tip for quantifying the single living cancer cells and nanosurface interaction B Wang, L Wang, X Li, Y Liu, Z Zhang, E Hedrick, S Safe, J Qiu, G Lu, ... Manufacturing letters 16, 27-31, 2018 | 3 | 2018 |
| Endocrine disruption: Relevance of experimental studies in female animals to human studies S Safe, X Li Current Opinion in Toxicology 3, 12-19, 2017 | 3 | 2017 |
| Chemical-induced estrogenicity S Safe, UH Jin, X Li Veterinary Toxicology (Third Edition), 805-816, 2018 | 2 | 2018 |
| A role and mechanism for redox sensing by SENP1 in β-cell responses to high fat feeding H Lin, K Suzuki, N Smith, X Li, L Nalbach, S Fuentes, AF Spigelman, ... Nature Communications 15 (1), 334, 2024 | | 2024 |
